VOYA Investment Management’s Arbutus Biopharma ABUS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $133K | Buy |
43,148
+1,625
| +4% | +$5.02K | ﹤0.01% | 2417 |
|
|
2025
Q1 | $145K | Sell |
41,523
-4,534
| -10% | -$15.8K | ﹤0.01% | 2352 |
|
|
2024
Q4 | $151K | Sell |
46,057
-2,460
| -5% | -$8.04K | ﹤0.01% | 2476 |
|
|
2024
Q3 | $187K | Sell |
48,517
-749
| -2% | -$2.88K | ﹤0.01% | 2502 |
|
|
2024
Q2 | $152K | Buy |
49,266
+4,361
| +10% | +$13.5K | ﹤0.01% | 2556 |
|
|
2024
Q1 | $116K | Sell |
44,905
-11,388
| -20% | -$29.4K | ﹤0.01% | 2600 |
|
|
2023
Q4 | $141K | Sell |
56,293
-82,678
| -59% | -$207K | ﹤0.01% | 2677 |
|
|
2023
Q3 | $282K | Buy |
138,971
+13,240
| +11% | +$26.9K | ﹤0.01% | 2341 |
|
|
2023
Q2 | $289K | Buy |
125,731
+83,523
| +198% | +$192K | ﹤0.01% | 2385 |
|
|
2023
Q1 | $128K | Hold |
42,208
| – | – | ﹤0.01% | 2656 |
|
|
2022
Q4 | $98.3K | Hold |
42,208
| – | – | ﹤0.01% | 2758 |
|
|
2022
Q3 | $80.6K | Hold |
42,208
| – | – | ﹤0.01% | 2828 |
|
|
2022
Q2 | $114K | Buy |
42,208
+11,271
| +36% | +$30.4K | ﹤0.01% | 2581 |
|
|
2022
Q1 | $92K | Hold |
30,937
| – | – | ﹤0.01% | 2521 |
|
|
2021
Q4 | $120K | Sell |
30,937
-905
| -3% | -$3.51K | ﹤0.01% | 2637 |
|
|
2021
Q3 | $137K | Hold |
31,842
| – | – | ﹤0.01% | 2671 |
|
|
2021
Q2 | $96K | Buy |
+31,842
| New | +$96K | ﹤0.01% | 2776 |
|
|
2019
Q2 | – | Sell |
-13,404
| Closed | -$48K | – | 2581 |
|
|
2019
Q1 | $48K | Hold |
13,404
| – | – | ﹤0.01% | 2511 |
|
|
2018
Q4 | $51K | Hold |
13,404
| – | – | ﹤0.01% | 2485 |
|
|
2018
Q3 | $127K | Hold |
13,404
| – | – | ﹤0.01% | 2456 |
|
|
2018
Q2 | $98K | Buy |
+13,404
| New | +$98K | ﹤0.01% | 2524 |
|